WDR75 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.105200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.171000E-01
Normal-vs-Stage2
6.653800E-01
Normal-vs-Stage3
4.803000E-01
Normal-vs-Stage4
4.844000E-01
Stage1-vs-Stage2
6.948400E-01
Stage1-vs-Stage3
6.622200E-01
Stage1-vs-Stage4
1.343250E-01
Stage2-vs-Stage3
3.380200E-01
Stage2-vs-Stage4
9.186000E-02
Stage3-vs-Stage4
1.153770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.409800E-01
Normal-vs-AfricanAmerican
4.853000E-01
Normal-vs-Asian
6.103600E-01
Caucasian-vs-AfricanAmerican
5.669800E-01
Caucasian-vs-Asian
7.811800E-01
AfricanAmerican-vs-Asian
7.574200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.602400E-01
Normal-vs-Female
6.751600E-01
Male-vs-Female
8.543000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.818400E-01
Normal-vs-Age(41-60Yrs)
7.132800E-01
Normal-vs-Age(61-80Yrs)
5.797800E-01
Normal-vs-Age(81-100Yrs)
8.195600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.637600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.247600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.028800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.866400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.600200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.134000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.969400E-01
Normal-vs-Daily Drinker
4.529200E-01
Normal-vs-Weekly Drinker
9.215800E-01
Normal-vs-Occasional Drinker
7.764800E-01
Normal-vs-Social Drinker
6.168000E-01
Non Drinker-vs-Daily Drinker
8.198600E-01
Non Drinker-vs-Weekly Drinker
1.031820E-01
Non Drinker-vs-Occasional Drinker
9.731900E-02
Non Drinker-vs-Social Drinker
3.214600E-01
Daily Drinker-vs-Weekly Drinker
1.671370E-01
Daily Drinker-vs-Occasional Drinker
2.089400E-01
Daily Drinker-vs-Social Drinker
4.411400E-01
Weekly Drinker-vs-Occasional Drinker
5.973200E-01
Weekly Drinker-vs-Social Drinker
4.297600E-01
Occasional Drinker-vs-Social Drinker
6.131400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.528400E-01
Normal-vs-Grade 2
6.128100E-02
Normal-vs-Grade 3
5.580100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.002320E-03
Grade 1-vs-Grade 3
1.377970E-03
Grade 1-vs-Grade 4
4.528400E-01
Grade 2-vs-Grade 3
6.353400E-01
Grade 2-vs-Grade 4
6.128100E-02
Grade 3-vs-Grade 4
5.580100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.427200E-01
Normal-vs-NonDiabetic
5.979200E-01
Diabetic-vs-NonDiabetic
5.187400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.718600E-01
Normal-vs-NoPancreatitis
5.559000E-01
Pancreatitis-vs-NoPancreatitis
7.601600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.462200E-01
Normal-vs-N1
6.705400E-01
N0-vs-N1
5.895200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.951800E-01
Normal-vs-TP53-NonMutant
4.370000E-01
TP53-Mutant-vs-TP53-NonMutant
1.65549999999737E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
